Breast CAncer

Study Reveals Promising Results for Using Serum Drug Levels to Monitor Adjuvant Tamoxifen Adherence in Early-Stage Breast Cancer

By

Susan Moench, PhD, PA-C

Publish Date July 13, 2020

In this study, the cutoff for biochemical adherence/nonadherence was a serum tamoxifen level of 60 ng/mL.

Early Breast Cancer Screening Benefits Childhood Cancer Survivors

Publish Date July 7, 2020

Early initiation of breast cancer screening with MRI may reduce breast cancer mortality by more than half.

Most Women Unaware of Breast Implant-Related Lymphoma

Publish Date July 13, 2020

Even among women with breast implants, just over half have heard of BIA-ALCL.

Applying Lessons Learned From Patient Navigation May Improve Breast Cancer Care in Vulnerable Populations

By

Susan Moench, PhD, PA-C

Publish Date July 10, 2020

Continuously-modified 4R care sequencing templates incorporating patient navigator learning was described as a means of facilitating breast cancer care delivery.

Exercise, Supportive Care Are Key to Managing Cancer-Related Fatigue in Patients With Cancer

By

Bette Weinstein Kaplan

Publish Date July 7, 2020

Research findings from ESMO confirm that patients with cancer can improve their symptoms of CRF if they “avoid inactivity”; in addition, greater use of supportive care can also help.

Nurse-Led Consultations of Cancer Survivors More Detailed Than Physician Assessments

By

Jessica Nye, PhD

Publish Date July 6, 2020

Survivorship care plan consultations led by breast care nurses reported significantly higher percentage of patients having issues, and were more likely to include referrals for follow-up appointments.

Medicaid Expansion Linked to Drop in Uninsured With Breast Cancer

Publish Date July 6, 2020

Significant reductions in uninsured patients, in advanced-stage disease, especially in African-Americans.

Phesgo Approval Allows for Faster Administration of Pertuzumab and Trastuzumab

By

Brian Park, PharmD

Publish Date July 2, 2020

The FDA has approved Phesgo™ (pertuzumab, trastuzumab, hyaluronidase-zzxf; Genentech), in combination with chemotherapy, for the treatment of early and metastatic HER2-positive breast cancer.

High Prevalence of Urinary Incontinence With Breast Cancer Suggests Potential Overlap of Risk Factors

By

Rick Maffei

Publish Date June 29, 2020

Researchers evaluated the prevalence, level, and impact on QOL of patient-reported urinary incontinence at baseline and after 3 months of systemic therapy.

Higher Levels of Outdoor Light at Night May Be Linked to Increased Breast Cancer Risk

By

Susan Moench, PhD, PA-C

Publish Date June 19, 2020

The incidence of breast cancer for postmenopausal women included in the NIH-AARP study was evaluated with respect to level of outdoor light at night.